Copertina

β‐alanine supplementation in adults with overweight and obesity: a randomized controlled feasibility trial

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Joseph J. Matthews, Jade V. Creighton, James Donaldson, Paul A. Swinton, Ioannis Kyrou, Srikanth Bellary, Iskandar Idris, Lívia Santos, Mark D. Turner, Craig L. Doig, Kirsty J. Elliott‐Sale, Craig Sale
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Obesity
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Adults who are overweight or obese may experience greater pain intensity compared with normal weight individuals?
di: Iskandar Idris
Pubblicazione: (2024)

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
di: Iskandar Idris, et al.
Pubblicazione: (2025)

Appropriate timing of exercise for adults with obesity including those with type 2 diabetes
di: Iskandar Idris
Pubblicazione: (2024)

Precision medicine approach to detect obese people who are at high risk of developing diabetes
di: Iskandar Idris
Pubblicazione: (2024)

Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity
di: Iskandar Idris
Pubblicazione: (2024)

Maternal folic acid supplementation during pregnancy in association with childhood overweight or obesity
di: Chi‐Yen Hung, et al.
Pubblicazione: (2024)

Hybrid closed‐loop therapy significantly improved maternal glucose control during pregnancy complicated by type 1 diabetes
di: Iskandar Idris
Pubblicazione: (2024)

The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy
di: Iskandar Idris
Pubblicazione: (2024)

Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer?
di: Iskandar Idris
Pubblicazione: (2024)

Tirzepatide shown to be effective at reducing sleep disturbances in patients with obstructive sleep apnoea
di: Iskandar Idris
Pubblicazione: (2024)

Can diet and exercise intervention prevent type 2 diabetes in individuals with a high genetic risk?
di: Iskandar Idris
Pubblicazione: (2024)

Extension study from DIRECT showed ongoing remission rate from type 2 diabetes in some patient following very low calorie diet at 5 years
di: Iskandar Idris
Pubblicazione: (2024)

Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
di: Iskandar Idris
Pubblicazione: (2024)

The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
di: Iskandar Idris
Pubblicazione: (2024)

Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied
di: Iskandar Idris
Pubblicazione: (2024)

Epigenetic changes shown to cause type 2 diabetes
di: Iskandar Idris
Pubblicazione: (2024)

Real world study provided reassurance of the safety of GLP‐1 therapy on mental health and suicide risk
di: Iskandar Idris
Pubblicazione: (2024)

Real world data showed that the dual GLP gip agonist, Tirzepatide is associated with lower mortality, cardiovascular events and adverse kidney events compared with GLP‐1 analogue
di: Iskandar Idris
Pubblicazione: (2024)

Increased expression of the protein Kallistatin after weight loss induces beneficial metabolic effects: A potential new therapeutic target?
di: Iskandar Idris
Pubblicazione: (2024)

Increasing excess to weight loss injection shown to save thousands of lives a year
di: Iskandar Idris
Pubblicazione: (2024)

Fenofibrate shown to reduce progression of diabetic retinopathy
di: Iskandar Idris
Pubblicazione: (2024)

Metabolic effects of an essential amino acid supplement in adolescents with PCOS and obesity
di: Talyia M. Fordham, et al.
Pubblicazione: (2024)

Obstructive sleep apnoea in obesity: A review
di: Jian E. Tai, et al.
Pubblicazione: (2024)

Exploring the perceptions of Chinese adults toward overweight and obesity: A systematic literature review
di: Yixi Wang‐Chen, et al.
Pubblicazione: (2025)

Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight
di: Donald M. Bushnell, et al.
Pubblicazione: (2025)

Myocardial mechano‐energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity
di: Chiara Maria Assunta Cefalo, et al.
Pubblicazione: (2024)

Clinical practice guidelines for the management of overweight and obesity published internationally: A scoping review
di: Cadeyrn J. Gaskin, et al.
Pubblicazione: (2024)

Neurological‐related proteomic profiling in plasma of children with metabolic healthy and unhealthy overweight/obesity
di: Marcos Olvera‐Rojas, et al.
Pubblicazione: (2024)

Modeling potential cost‐effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity
di: Meredith M. Hoog, et al.
Pubblicazione: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
di: Jia‐Jie Wang, et al.
Pubblicazione: (2024)

Sleep‐disordered breathing and cardiometabolic and inflammatory markers in children with overweight/obesity: The role of cardiorespiratory fitness
di: Lucia V. Torres‐Lopez, et al.
Pubblicazione: (2025)

Musculoskeletal characteristics in older adults with overweight or obesity: INVEST in Bone Health trial baseline analysis
di: S. Delanie Lynch, et al.
Pubblicazione: (2025)

Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study
di: Testimony Ipaye, et al.
Pubblicazione: (2025)

Potential pathways to the onset and development of eating disorders in people with overweight and obesity: A scoping review
di: Rabia Khalid, et al.
Pubblicazione: (2024)

Psychological well‐being and the reversal of childhood overweight and obesity in the UK : a longitudinal national cohort study
di: I Gusti Ngurah Edi Putra, et al.
Pubblicazione: (2024)

Exercise and diet effects on delay discounting and related neurobiology in adults with overweight or obesity: A randomized trial
di: Kelly T. Cosgrove, et al.
Pubblicazione: (2025)

Impact of COVID‐19 pandemic on sleep parameters and characteristics in individuals living with overweight and obesity
di: Stephen A. Glazer, et al.
Pubblicazione: (2024)

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
di: Jamy D. Ard, et al.
Pubblicazione: (2025)

Association of adverse childhood experiences and overweight or obesity in adolescents: A systematic review and network analysis
di: Renato Mikio Moriya, et al.
Pubblicazione: (2024)

The impact of overweight and obesity on health outcomes in the United States from 1990 to 2021
di: Omar Al Ta'ani, et al.
Pubblicazione: (2024)